A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)
暂无分享,去创建一个
Susan M. Chang | M. Prados | L. Deangelis | T. Cloughesy | K. Lamborn | N. Butowski | K. Fink | L. Junck | L. Abrey | A. Salazar
[1] Jeon-Soo Shin,et al. Double‐stranded RNA mediates interferon regulatory factor 3 activation and interleukin‐6 production by engaging Toll‐like receptor 3 in human brain astrocytes , 2008, Immunology.
[2] T. Seya,et al. TLR3: interferon induction by double-stranded RNA including poly(I:C). , 2008, Advanced drug delivery reviews.
[3] A. Hovanessian. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2'-5'oligoadenylate synthetases and the protein kinase PKR. , 2007, Cytokine & growth factor reviews.
[4] Junichi Eguchi,et al. Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models , 2007, Journal of Translational Medicine.
[5] G. Barber,et al. PKR in innate immunity, cancer, and viral oncolysis. , 2007, Methods in molecular biology.
[6] R. Silverman,et al. Tumour suppressor function of RNase L in a mouse model. , 2007, European journal of cancer.
[7] R. G. van der Most,et al. Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunity. , 2006, Cancer research.
[8] M. Morse,et al. Combining cancer vaccines with chemotherapy , 2005, Expert opinion on pharmacotherapy.
[9] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[10] Keith L Black,et al. Clinical Responsiveness of Glioblastoma Multiforme to Chemotherapy after Vaccination , 2004, Clinical Cancer Research.
[11] R. Dick,et al. Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations , 2004, Journal of Neuro-Oncology.
[12] M. Adamo,et al. Double-stranded ribonucleic acid decreases c6 rat glioma cell proliferation in part by activating protein kinase R and decreasing insulin-like growth factor I levels. , 2002, Endocrinology.
[13] L. Stewart,et al. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials , 2002, The Lancet.
[14] Reto Meuli,et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Radosevich,et al. Interferon-Responsive Protein Kinase (p68) and Proliferating Cell Nuclear Antigen Are Inversely Distributed in Head and Neck Squamous Cell Carcinoma , 1997, Tumor Biology.
[16] A. Ommaya,et al. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. , 1996, Neurosurgery.
[17] M. Mathews,et al. Activation of the double-stranded RNA (dsRNA)-activated human protein kinase in vivo in the absence of its dsRNA binding domain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Graham. Meta‐analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults , 1993, Cancer.
[19] D. Nelson,et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.
[20] M. Katze,et al. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Talmadge,et al. Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethyl cellulose [Poly(I,C)-LC]. , 1992, International journal of immunopharmacology.
[22] K. Black,et al. Inflammatory leukocytes associated with increased immunosuppression by glioblastoma. , 1992, Journal of neurosurgery.
[23] D. Longo,et al. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects. , 1992, Cancer research.
[24] A. Hovanessian. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2',5'-oligoadenylate synthetases. , 1991, Journal of interferon research.
[25] T. Cascino,et al. Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] W. Yung,et al. Growth Inhibitory Effects of Interferon-β but Not Interferon-α on Human Glioma Cells: Correlation of Receptor Binding, 2′,5′-O1igoadenylate Synthetase and Protein Kinase Activity , 1990 .
[27] M. Katze,et al. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. , 1989, European journal of biochemistry.
[28] A. Cook,et al. Growth of Astrocytomas in the Human Tumor Clonogenic Assay and Sensitivity to Mismatched dsRNA and Interferons , 1987, American journal of clinical oncology.
[29] N. Bleehen,et al. An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. , 1987, British Journal of Cancer.
[30] M. Droller. Immunotherapy of metastatic renal cell carcinoma with polyinosinic-polycytidylic acid. , 1987, The Journal of urology.
[31] P. Disaia,et al. Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC)). , 1986, Gynecologic oncology.
[32] G. Hortobagyi,et al. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer. , 1986, Cancer treatment reports.
[33] E. Borden,et al. An Eastern Cooperative Oncology Group phase I-II pilot study of polyriboinosinic-polyribocytidylic acid poly-L-lysine complex in patients with metastatic malignant melanoma. , 1985, Journal of biological response modifiers.
[34] W. Stewart,et al. Phase I trials of poly(I,C) complexes in advanced cancer. , 1985, Journal of biological response modifiers.
[35] K. Foon,et al. Immunomodulatory effects of poly(I,C)-LC in cancer patients. , 1985, Journal of biological response modifiers.
[36] Levy Hb. Historical overview of the use of polynucleotides in cancer. , 1985 .
[37] J. Adams,et al. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2. , 1985, Journal of immunology.
[38] J. Talmadge,et al. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. , 1985, Cancer research.
[39] H. Levy. Historical overview of the use of polynucleotides in cancer. , 1985, Journal of biological response modifiers.
[40] H. Hubbell,et al. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA. , 1984, Cancer research.
[41] K. Takakura,et al. Phase I-II trials of poly(ICLC) in malignant brain tumor patients. , 1982, Journal of interferon research.
[42] Levine As,et al. Antitumor effects of interferon and poly ICLC, and their possible utility as anti-neoplastic agents in man. , 1981 .
[43] A. Levine,et al. Antitumor effects of interferon and poly ICLC, and their possible utility as anti-neoplastic agents in man. , 1981, Texas reports on biology and medicine.
[44] A. Anderson,et al. IMMUNE MODULATING EFFECTS OF POLY ICLC , 1980, Annals of the New York Academy of Sciences.
[45] C. Baglioni,et al. Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. , 1979, The Journal of biological chemistry.